Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 90-96, May 2006

Cutaneous T-Cell Lymphoma

  • Robin Gemmill

      Affiliations

    • Corresponding Author InformationAddress correspondence to Robin Gemmill, MSN, RN, CNS, CWOCN, City of Hope National Medical Center, Duarte, CA

City of Hope National Medical Center, Duarte, CA

Objective

To review recent information on the epidemiology, etiology, clinical presentation, staging, treatment approaches, and nursing management of CTCL.

Data Sources

Research and review articles and textbooks.

Conclusion

Identifying the etiology and finding a cure for cutaneous T-cell lymphoma is promising as our knowledge and understanding of the T-cell biology evolves, creating more options for innovative therapies or treatment modalities.

Implications for Nursing Practice

It is essential for the oncology nurse to understand the disease process, treatment modalities, and side effect profiles to provide astute nursing assessment, establishment of treatment goals, management of cutaneous symptoms, treatment of side effects, and pain control while preventing infection and providing psychological/social support throughout the course of the disease.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 12.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0749-2081(06)00014-3

doi:10.1016/j.soncn.2006.01.005

Seminars in Oncology Nursing
Volume 22, Issue 2 , Pages 90-96, May 2006